Adeptus Health Reports Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
July 22, 2016 8:54 AM EDTJefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following the company's 2Q earnings report. Q2 results mostly came in below expectations and at the low end of management's guidance. Jefferies does not expect meaningful... More
Adeptus Health (ADPT) Misses Q2 EPS by 3c
July 21, 2016 6:52 AM EDTAdeptus Health (NYSE: ADPT) reported Q2 EPS of $0.48, $0.03 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $100.2 million versus the consensus estimate of $93.92 million.
2016 Guidance Reaffirmed
We continue to expect systemwide net patient services revenue, which includes revenue... More
